News & Events :: Pasithea Therapeutics Corp. (KTTA)

Recent News View All News

Apr 1, 2026 7:01am EDT

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity

Feb 17, 2026 7:01am EST

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Recent Events View IR Calendar

Feb 26, 2026 4:00 pm EDT

Oppenheimer 36th Annual Healthcare Life Sciences Conference

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings